Figure 1.
QCLGF alleviates d-galactosamine-induced liver injury. (A) Plasma ALT and AST levels were determined 12 h after D-GalN intraperitoneal injection. (B) Liver HAI score. (C) Representative liver sections from different treated groups (n = 6, per group). (*P < 0.05, **P < 0.01 and ***P < 0.001 compared with the ALF group, Wilcoxon rank sum test).